PRESENTATION

H1 FY2025 — Results presentation

H1 FY2025PDF · 81 pages5.2 MB
Unaudited Interim Results
and cash dividend declaration for the six
months ended 31 December 2024

-- 1 of 81 --

2
Performance overview
Normalised
profit
+27%
to R7 020m
New
business1
-12%
to R12 534m
+6% when excluding
Sasolmed in prior period
Headline
earnings
+34%
to R4 267m
Normalised
headline earnings
+34%
to R4 350m
1 Excluding discontinued products like VitalityInvest, DBI and Ping An Health reinsurance business
Non-insurance
income
+14%
to R3 181m

-- 2 of 81 --

3
Key insights from H1 FY2025 performance
1
2
3
The structuring of the group into two composites has been completed,
with the Group in a new phase of growth and performing well
The Vitality Shared-value model is a key driver of performance4
The growth is consistently strong across the two composites and
within the businesses
The Group is financially resilient in a complex and uncertain
environment
Growth
Shared value
Consistency
Resilience

-- 3 of 81 --

4
0
1,000
2,000
3,000
4,000
5,000
6,000
7,000
Strong profit performance
Health 2 023 +8%
Life 2 612 +15%
Invest 904 +46%
Insure 401 +1905%
Bank -145 -57%
Other SA1 -275 +216%
SA 5 520 +27%
Vitality Health 599 +14%
Vitality Life 327 +8%
Vitality Network 339 +15%
Ping An Health Insurance 424 +23%
VHI - Other -149 -14%
Other Vitality -40 -33%
Vitality (UK and VG) 1 500 +27%
Normalised profit, ZARm
1 Vitality, Other SA Initiatives and Group initiatives and central costs
to R7 020m
IFRS 17
+27%
Strong normalised profit growth

-- 4 of 81 --

5
Strong performance
Health 4 714 -31% 646 +9%
Life 1 463 -4%
Invest 1 735 +7%
Insure 659 -1%
Bank 1 100 +42%
Other SA1 448 +22%
SA 9 019 -18% 1 746 +27%
Vitality Health 1 326 +2%
Vitality Life 1 101 +18%
Vitality Network 970 +3%
Ping An Health Insurance 1 088 +6%
VHI - Other 465 -2%
Other Vitality
Vitality (UK and VG) 3 515 +8% 1 435 +1%
New
business2
Non-insurance
income	ZARm
1 Vitality and other SA Initiatives 2 Excl products in run down
to R12 534m to R3 181m
New business growth
impacted by Sasolmed
-
2,000
4,000
6,000
8,000
10,000
12,000
14,000
16,000
H1
2021
H1
2022
H1
2023
H1
2024
H1
2025
Sasolmed
Robust non-insurance
income growth
+6%
-
500
1,000
1,500
2,000
2,500
3,000
3,500
H1
2021
H1
2022
H1
2023
H1
2024
H1
2025
+14%Excl Sasolmed in
prior period
-12%

-- 5 of 81 --

6
-20%
0%
20%
40%
Entering a new phase of growth
% spend
on new
Dividend
cover
Cash
conversion
ratio
(normalised history)
Normalised
profit
growth
FLR
RoE
Scaled organic growth
15-20%
RoE
15-20%
CAGR
c5%
Spend on
new
10-20%
FLR
≤5x
Dividend
cover
60-70%
Cash
conversion ratio
Forward looking information on this slide is for illustration and has not been reviewed or reported on by the auditors and reflects the average expected over the time frame
15%
H1FY25
18%
H1FY25
30-40% of
expected full
year dividend
at H1FY25
27%
H1FY25
5%
H1FY25
75%
H1FY25
0%
20%
40%
60%
80%
Illustrative ranges
0%
10%
20%
30%
0%
10%
20%
30%
Big investments in New	Unfettered organic growth
Average 13%	Average 20%
Average 22%
Average
3%
4.6x 5.7x
CAGR
IFRS 4
9%	CAGR 22%
8% 15%
56%	60%
Average
Average
Average
Average
Average
Average
FY
2006
FY
2007
FY
2008
FY
2009
FY
2010
FY
2011
FY
2012
FY
2013
FY
2014
FY
2015
FY
2016
FY
2017
FY
2018
FY
2019
FY
2020
FY
2021
FY
2022
FY
2023
FY
2024
FY
2026
FY
2027
FY
2028
FY
2029
H1
2025
Above
plan
Within
plan
Expected FY25
Within
plan
Within
plan
Within
plan
Within
plan
0%
10%
20%
30%
-
2
4
6
H1 FY25

-- 6 of 81 --

7
Well positioned for future growth
Expect continued organic growth Average expected earnings growth ambition
Profitability
Discovery Group
Forward looking information on this slide is for illustration and has not been reviewed or reported on by the auditors
SA
Growth
Vitality
Growth
0%
5%
10%
15%
20%
25%
30%
12.5
-17.5%
20
-30%
p.a. (FY25-FY29)

-- 7 of 81 --

8
Strong ambition in each composite
12.5% - 17.5% p.a.
Earnings growth
FY25-FY29
c15%
Revenue growth (USD)
c50%
Operating margin
>10%
Premium growth (GBP)
>RF+5%
Life new business IRR
c7.5%
Health gross margin
>RF+10
Hurdle return on capital
FY27
Vitality USA break-even	
VHI
-other
>5%
Premium growth above market
PAHI	
Preserving quality profit growth
Growth ambitions
20% - 30% p.a.
Earnings growth
FY25-FY29
>RF+8%
Life and Invest new business IRR
c10%
Insure margin
R400m Bank operating profit growth p.a.
R3bn Bank FY29 profit ambition
Vitality UK Vitality Network Vitality Health International	Discovery SA
Forward looking information on this slide is for illustration and has not been reviewed or reported on by the auditors and reflects the average expected over the time frame

-- 8 of 81 --

9
The mathematics of growth - actual better than expected
Forward looking information on this slide is for illustration and has not been reviewed or reported on by the auditors and reflects the average expected over the time frame
Outperformed against targets in period
H1 FY2025 cumulative profit growth contribution
Expect strong profit growth from composites
Expected average growth contribution (FY25-FY29)
0%
5%
10%
15%
20%
25%
30%
SA excl bank SA Vitality Total
0%
5%
10%
15%
20%
25%
30%
SA excl bank SA Vitality Total	Bank Bank
15% to
20%
c10%
+ c5%
+ c3%
27%
21%
+ 6% + 0%
Target
corridor of
growth
Target
corridor of
growth

-- 9 of 81 --

10
Consistently strong growth across all businesses
Health Life Invest Insure Bank
Vitality
Health
Vitality
Life
Vitality
Network
+57%	+8%
Normalised profit
(H1 FY25 Growth)
+15% +46% >100% +14% +8% +15%
Ping An
Health
Insurance
+23%

-- 10 of 81 --

11
Supportive below the line performance for the six months
Interim ordinary dividend declaration of 87cps, a 34% increase in line
with growth in normalised headline earnings
R million
Actual Actual
%	H1 2025 H1 2024
Normalised profit from operations 7 020 5 536 27%
Forex gains/(losses) 13 -40
1 DP finance lease impact -44 -59
Finance charges excl. 1DP finance lease -954 -881
Investment income and fair value gains on financial instruments 260 195
Other -126 -72
Profit before tax 6 169 4 679 32%
Taxation -1 840 -1 401
Profit after tax 4 329 3 278 32%
Profit not attributable to ordinary shareholders -100 -88
Loss on disposal/derecognition of property and equipment 2 2
Loss on derecognition of intangible assets 16 4
Loss on dilution and disposal of equity accounted investments 20
Headline earnings 4 267 3 196 34%
Amortisation of intangibles from business combinations 47 45
Restructuring costs 36 15
Normalised headline earnings 4 350 3 256 34%

-- 11 of 81 --

12
Non-covered Covered	Opening EV Value of new
business
Unwind of risk
discount rate
Non-economic
experience
variances and
methodology &
assumption
changes
Non-covered
businesses
Operational EV Economic
experience
variances and
methodology &
assumption
changes
Forex Finance costs,
investment
income and
other
Change in
capital and
dividends
Closing EV
Solid growth in Group Embedded Value
R119 422m
R110 354m
R119 616m
19%
(18% excl all economic basis updates)
c30% of Group
revenue is not
covered in EV
Revenue split by
covered vs non-covered
businesses
c30%
Annualised RoEV

-- 12 of 81 --

13
-
500
1,000
1,500
2,000
2,500
3,000
3,500
H1
2021
H1
2022
H1
2023
H1
2024
H1
2025
10%
15%
20%
25%
30%
H1 FY23
FY23
H1 FY24
FY24
H1 FY25
Group well capitalised with robust cash generation
FLR decreasing Strongly capitalised
Improving cash
conversion
Sufficient centre
liquidity
DHMS solvency
(unaudited) 31%
1 Capital Adequacy Ratio ; 2 Comprehensive Solvency Ratio, definition set by China Banking and Insurance Regulatory Commission ; 3 Centre cash + undrawn committed facilities ; 4 Normalised for COVID-19 reserve impact, refer to Annexure A
28%
18%
FLR
Dec 23
Cover
Dec 24
Cover
Life 1.8x 1.8x
Insure 1.5x 2.0x
VH 1.4x 1.7x
VL 2.3x 2.0x
Bank1 1.3x 1.2x
PAHI2 3.1x 3.4x
Group cash conversion ratio4	Centre liquidity3, Rm
75%
R3.2bn
(R1.1bn of which
will be used to repay
maturing debt by
March 2025)
Solvency cover
Required buffer
0%
20%
40%
60%
80%
H1
2021
H1
2022
H1
2023
H1
2024
H1
2025

-- 13 of 81 --

14
Health
Discovery
Life and
Invest
Vitality
Health
Vitality
Life
Robust cash generation drives strong cash conversion
Cash uses (Rbn)
R8.3bn
Cash
generated
from in-force
Cash
generated
Discovery
New business
and tax
Operating
cash flow
-R3.5bn
New business
net of
external
funding
R4.0bn-R0.8bn
Tax
75%cash
conversion
ratio
1.1
0.9
0.7 0.6 0.5
0.2
Dividends Finance costs New
initiatives
Existing
business
development
Repayment of
debt
Financing &
matching
Servicing
cost
Investment
in growth
Capital
movements
Cash conversion ratio is calculated as Operating Cash Flow (R4 055m at 31 December 2024, from the ‘Additional Analyst Information’ document) over the IFRS normalised profit/(loss) from operations (R7 276m at 31
December 2024, from note A.1 Segment Information of the ‘Unaudited Interim Results’) net of IFRS income tax expense (R1 840m at 31 December 2024, from note A.1 Segment Information of the ‘Unaudited Interim Results’)

-- 14 of 81 --

15
Increasingly complex environment, with risks mounting on all
fronts
The world is growing increasingly complex, with risks mounting on all fronts and optimism fading about the ability of institutions to manage them.
Geopolitical tensions, economic instability, and trade wars are fueling uncertainty, while AI-driven misinformation erodes public trust. At the same time,
climate challenges, resource shortages, and a weakening of multilateral cooperation further complicate coordinated responses to emerging crises
ECONOMIC
Global economic risks have shifted from immediate
inflation concerns to broader fears of stagnation,
supply chain disruptions, and asset market instability
GEOPOLITICAL
The world is experiencing a "geopolitical recession,"
where traditional alliances are weakening, and new
regional power struggles are emerging
SOCIOPOLITICAL
Social cohesion is weakening due to rising
misinformation and deepening ideological divisions.
Governments worldwide are struggling to balance
security measures with the protection of civil rights
ENVIRONMENTAL
The economic costs of extreme weather events are
rising, disproportionately impacting vulnerable
communities. Water and food security are emerging
as global flashpoints, requiring immediate action
TECHNOLOGICAL
Technology is evolving faster than governance
structures can adapt, creating new vulnerabilities -
concerns about misinformation, surveillance, and job
displacement gaining traction
•
Economic downturn (recession,
stagnation)
•
Disruptions to a systemically important
supply chain
•
State-based armed conflict
•
Geoeconomic confrontation
(sanctions, tariffs, etc.)
Source: WEF Global Risks Report 2025; The Global Risks Report 2025 20th Edition Insight Report
•
Misinformation and disinformation
•
Societal polarisation
•
Erosion of human rights/civic freedoms
•
Extreme weather events
•
Natural resource shortages
•
Critical change to Earth systems
•
Adverse outcomes of AI technologies
•
Cyber espionage and warfare
•
Online harms (fraud, misinformation,
etc.)
Global risks interconnection
map

-- 15 of 81 --

16
Strong risk governance ensures minimal exposure
Set of defined risk principles Minimal risk exposure due to geographic diversification
1. Liability matching: Liabilities matched by
currency, nature and duration
2. Interest rates hedged: Interest rate
fluctuations that affect solvency and liquidity
will be hedged out
3. Currency matching: Cross-currency
expenses will be immunised via forward
currency instruments, and debt is serviced
from cashflows in country in which debt is
denominated
4. Appropriate liquidity buffers: Appropriate
cash buffers are held in all regulated entities
5. Mitigate lapse risk: Where economically
feasible lapse risk will be mitigated through
non-recourse financial reinsurance
arrangements, and mass lapse protection
6. Monitor new initiatives: Focus on key
initiatives will be intensified and new
initiatives that have marginal benefit will be
ceased
Only 20% of debt is not fixed, with
exposure to UK interest rates
Limited short-term offshore funding
planned (VG)
SA
Bank
Debt
23%
SA DMTN
Debt
57%
UK Bank Debt
20%
Fixed,
80%
Floating,
20%
Composition of Group debt FY24
1% increase in
SONIA is c4%
increase in
finance cost bill
(R77m p.a.)
Cash from the centre, Rm
-
500
1,000
1,500
2,000
2,500
3,000
3,500
4,000
4,500
5,000
Bank VG UK Insure
FY25-
FY29
Forward looking information on this slide is for illustration and has not been reviewed or reported on by the auditors

-- 16 of 81 --

17
50%
60%
70%
80%
90%
100%
110%
FY2025 FY2026 FY2027 FY2028 FY2029
50%
60%
70%
80%
90%
100%
110%
FY2025 FY2026 FY2027 FY2028 FY2029
50%
60%
70%
80%
90%
100%
110%
FY2025 FY2026 FY2027 FY2028 FY2029
Equity stress
Interest rate and inflation up
Group remains resilient to economic uncertainty
*Stresses broadly parameterised at 1-in-25-year level
Forward looking information on this slide is for illustration and has not been reviewed or reported on by the auditors
Operating cash flow Headline earnings Group solvency
Inflation Up (permanent)
SA inflation +100bps
UK inflation +50bps
Inflation Down (permanent)
SA inflation -100bps
UK inflation -50bps
Rand Appreciation
25% ZAR appreciation
Equity Stress
30% reduction to asset value
with no recovery
Nominal Interest Down
(permanent)
SA nominals -100bps
UK nominals -50bps
Interest Rate and Inflation
Up (permanent)
SA nominals +100bps
UK nominals +50bps
Stresses are calibrated
to reflect severe but
plausible events*
Equity shock and rand appreciation
are the worst stresses
Rand appreciation is the worst stress	
Inflation up is the worst stress
Base
Inflation up Nominal interest down
Rand appreciation Inflation down
Stresses relative to base (base scenario rebased to 100%)

-- 17 of 81 --

18
Significant status correlations
Lapses
Deposits
CLR 95%
Lower
credit loss
ratio
11x
More
deposits
69%
Lower
paid-ups
48%
Lower
withdrawals
31%
Lower
claims
79%
Lower
lapses
57%
Lower
claims
53%
Lower
lapses
Claims
Life insurance Health insurance Motor insurance Long-term savings Banking
Blue
Bronze
Silver
Gold
Diamond
Blue
Bronze
Silver
Gold
Diamond
22%
Lower
claims
65%
Lower
lapses
2024 experience
Blue
Bronze
Silver
Gold
Diamond
Blue
Bronze
Silver
Gold
Diamond
Blue
Bronze
Silver
Gold
Diamond
Blue
Bronze
Silver
Gold
Diamond
Blue
Bronze
Silver
Gold
Diamond
Blue
Bronze
Silver
Gold
Diamond
Blue
Bronze
Silver
Gold
Diamond
Blue
Bronze
Silver
Gold &
Diamond

-- 18 of 81 --

19
Vitality SA experienced considerable engagement
Increase in status
distribution
Increased
engagement
Increased travel
bookings
Increased
HealthyFood spend
% members Bronze
and above
Total Active Rewards
gameboard plays
Flights bookings and prices HealthyFood spend
H1 2024 H1 2025
+11%
Tickets
booked
Avg
ticket
price
Tickets
booked
Avg
ticket
price
Domestic International
H1 2024 H1 2025
H1 2024 H1 2025
+8% +14%
+26%
+6%
+18%
0%
50%
100%
150%
200%
Jul-23	
Sep-23	
Nov-23	
Jan-24	
Mar-24	
May-24
Jul-24	
Sep-24	
Nov-24
+36%
H1 24 to H1 25
flights booked	Vitality
members
Vitality points-
earning workouts
HealthyFood
spend52m 1.1m R3.4bn	2.4m
New
partner
launched
HealthyFood
baskets
28m
All figures for 2024

-- 19 of 81 --

20
The power of the Vitality Shared-value model in dealing with
profound change
Long-term
savings
Short-term
insurance
Banking
• Transfer of risk moving from Defined Benefit to Defined
Contribution
• Supply chain disruptions post COVID-19
• Rising climate volatility and catastrophe risk
• Commoditisation and digital distribution
• Shift to ‘skinny banks’ – commoditised and low service, with a
focus on transaction accounts and payment processing
Health
insurance
• Fiscal pressures on public healthcare
• Ageing populations
• Increasing chronicity
• Escalating technology costs
Rapid medical
inflation
Inadequate
retirement
savings
Margin pressure
and volatile profits
Multi-banked
clients
Life
insurance
• Massive and mature industry
• Capital-intensive with long payback periods
• Commoditisation and digital distribution
• Consumer duty and treating customers fairly
Acceptable return
on capital
Trends Challenge

-- 20 of 81 --

21
+27% +27%
H1 FY25 profit growth:

-- 21 of 81 --

22
Discovery SA
Discovery CEB	
Discovery Insure	
Discovery Invest	
Discovery Bank	
Discovery Life	
Discovery Health
 Strong earnings and core new business growth (up 9%
excl the new closed scheme Sasolmed in prior period)
Strong earnings and cash generation with positive
claims experience and maintained its retail market
share and new business margins, while Group Life new
business declined
Significant earnings growth benefitting from strong
market performance and some one-off gains for the
period
Excellent margin achieved from diligently executed
business actions, with benign weather conditions
(severe in prior period)
Excellent performance across all key metrics and
achieved monthly operational break-even ahead of
target

-- 22 of 81 --

23

-- 23 of 81 --

24
G
L
O
B
A
L	
B
A
N
K
I
N
G	
T
R
E
N
D
S Data-centric hyper-personalisation
Integrated holistic ecosystem
Generative AI as the operational backbone
Democratising private banking through the
use of Generative AI, and personalising
financial products at scale
Integrating personalised data analytics,
gamification, and real-time redemption
options, creating more engaging and
tailored customer experiences
Discovery Bank and market trends
Using behavioural data to dynamically adjust
rewards based on real-time health and spending
data, using AI and predictive analytics to
anticipate customer needs and nudge
behaviours
Growing emphasis on integrating
banking into broader ecosystems, such as
retail platforms, to reach new segments
and provide comprehensive services
Phygital banking: blending digital
agility with human trust
Seeking app-based convenience, while
retaining the affinity for tangible interactions -
acknowledging diverse customer preferences
Cybersecurity prioritisation
Embedding encryption and anomaly
detection into core systems to combat fraud
and AI deepfakes promoting financial scams
Leveraging fintech to enhance
rewards programmes
#1 - Smart, simple and easy products
#1 - Best service and experience
#1 - Top private banking provider
#1 - Excellent benefits and rewards
#1 - Best emotional experience
#1 - Best relationships with clients

-- 24 of 81 --

25
Discovery Bank
Deposits Normalised profit	Revenue (NII+NIR)
+32% +27% +57%	+42%
to 1.1m to R21.2bn to (R145m)	to R1.1bn
H1
2021
H1
2022
H1
2023
H1
2024
H1
2025
Accounts Clients
H1
2021
H1
2022
H1
2023
H1
2024
H1
2025
H1
2021
H1
2022
H1
2023
H1
2024
H1
2025
NII NIR
Advances
+37%
to R7.8bn
Total
accounts
Total
clients
+35%
to 2.6m
H1
2021
H1
2022
H1
2023
H1
2024
H1
2025
H1
2021
H1
2022
H1
2023
H1
2024
H1
2025

-- 25 of 81 --

26
(300)
(250)
(200)
(150)
(100)
(50)
-
Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2
FY2022 FY2023 FY2024 FY2025
Achieved run-rate break-even ahead of target
−
R169m R37m
Operating income Expenses New business
acquisition costs Profit / (loss) before tax	− =
R400m
operating profit growth p.a.
(i.e. before acquisition costs)
Short- to medium-term real growth target
Normalised operating
expenses1 (Rm) NBAC per new client2 (R) Profit (loss) before tax (Rm)	NII + NIR (Rm)
− −
6% CAGR	56% CAGR -3% CAGR
− −
R207mJan
2025
H1
FY25
-
100
200
300
400
500
600
700
Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2
FY2022 FY2023 FY2024 FY2025
-
100
200
300
400
500
600
Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2
FY2022 FY2023 FY2024 FY2025
-
200
400
600
800
1,000
1,200
1,400
1,600
1,800
2,000
Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2
FY2022 FY2023 FY2024 FY2025
R1 031m R214m	R1 100m
1 Includes fair value adjustments | 2 New Business Acquisition Costs represent the upfront expenses incurred to acquire new clients. Revenue generation from these clients occurs over time as they increase engagement with their Discovery Bank
account. As a result, NBAC reflects an initial investment with deferred returns. Forward looking information on this slide is for illustration and has not been reviewed or reported on by the auditors
Profitable
in Dec

-- 26 of 81 --

27
Attributes driving Discovery Bank growth
*Through-The-Cycle; adjusted average to measure the expected credit losses over an extended period, rather than in the current reporting cycle
Shift towards
credit products
Relevance from
outside DSY
Superior credit
quality maintained
Revenue driven
by engagement
Growing home
loans book
Daily growth
maintained
Daily sales per
business day
New-to-Bank
product mix
New business by
Discovery product
take up
Engagement per
client
Credit loss ratio vs
market
Value of home
loans disbursed,
Rm
400
600
800
1,000
1,200
1,400
1,600
Jul-22	
Oct-22	
Jan-23	
Apr-23	
Jul-23	
Oct-23	
Jan-24	
Apr-24	
Jul-24	
Oct-24	
Jan-25
45%
45%
46%
42%
47%
51%
50%
55%
55%
54%
58%
52%
49%
50%
Transaction PAYT and
Savings
Credit, Suite & TRX
Bundled
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
Jul-22	
Oct-22	
Jan-23	
Apr-23	
Jul-23	
Oct-23	
Jan-24	
Apr-24	
Jul-24	
Oct-24
With no Discovery
products
With a Discovery
product
0
100
200
300
400
500
600
700
0 1 2 3 4 5 6 7 8 9 10 11 12
Months after joining the
Bank
Payment value
Number payments
>6x
149
1,039
Sep-24 Jan-25
H1 25	
H1 24	
H1 23	
H1 22
H2 22	
H2 23	
H2 24
*
>65%
With no
Discovery
products
0%
1%
2%
3%
4%
5%
6%
7%
Market average
Discovery
CLR TTC
As at Dec24:
Growing market
share, currently 2%
Switching market
share of 9%

-- 27 of 81 --

28
Shared value in Discovery Bank
Total deposits Probability of default Credit loss rate	1 – 90 days arrears
89% lower probability of
default
97% lower arrears rate >95% lower credit loss
rate
11x more deposits
NIR per client
NIR by VM status
(indexed to Blue)
Months on book
0
100
200
300
400
500
600
700
800
1 - 3 4 - 6 7 - 12 13 - 24
Blue Bronze
Silver Gold
Diamond
Jun-21	
Nov-21	
Apr-22	
Sep-22	
Feb-23	
Jul-23
Dec-23	
May-24	
Oct-24
Blue Bronze
Silver Gold
Diamond

-- 28 of 81 --

29

-- 29 of 81 --

30
H1
2021
H1
2022
H1
2023
H1
2024
H1
2025
H1
2021
H1
2022
H1
2023
H1
2024
H1
2025
Discovery Health
*Sasolmed contributed R2 510m to new business for FY2024
Normalised profit New business Non-scheme growth	Membership
+8% -31% 3.96m
to R2 023m to R4 714m Lives under
administration >412k lives
+21%
Sasolmed* closed scheme
Excluding Sasolmed
in prior period: +9%
Jan-18	
Aug-18	
Mar-19	
Oct-19
May-20	
Dec-20
Jul-21
Feb-22	
Sep-22	
Apr-23	
Nov-23	
Jun-24
Flexicare
Gap cover
Healthy Company
1993
1996
1999
2002	
2005	
2008
2011
2014
2017
2020	
2023	
2024
Non Scheme Products
Restricted Schemes
DHMS

-- 30 of 81 --

31
0%
1%
2%
3%
2020-21 2021-22 2022-23 2023-24 2024-25
Upgrades Downgrades
0%
5%
10%
15%
20%
25%
30%
35%
40%
0
5
10
15
20
25
30
35
2020-21 2021-22 2022-23 2023-24 2024-25
Reserve Actual Solvency Required Solvency
Discovery Health Medical Scheme: continued excellent performance
in a complex environment
Membership and open market share as at June 2024	
Plan changes exclude impact of plan closures
Membership Customer satisfaction Solvency
57.9% market share Low proportions of members change plans, with
more members upgrading than downgrading:
Lapses continue to remain stable
R29.4bn
31%
AAA
projected unaudited reserves
projected unaudited solvency
credit rating
R billion
95% no plan changes
DHMS Rest of the industry
Others 0%
2%
4%
6%
8%
10%
2020-21 2021-22 2022-23 2023-24 2024-25

-- 31 of 81 --

32
DHMS’s growing contribution differential enhances market
competitiveness into 2025
Weighted average contribution increase (%) Comparison of average contributions
9.3% 9.4% 9.6%
10.2%
10.8%
12.8%
12.4%
2018 2019 2020 2021 2022 2023 2024 2025
Discovery Health Medical Scheme Next 7 largest open schemes
-11.1%
-12.3%
-14.6%
-16.3%
-14.4%
-13.3%
-14.3%
-12.7%
Scheme
1
Scheme
2
Scheme
3
Scheme
4
Scheme
5
Scheme
6

-- 32 of 81 --

33
Addressing the cost of healthcare
Age distribution of lives (2008 – 2024)
Sustained aging of the Scheme Increased chronicity continues across age groups
0.0%
0.5%
1.0%
1.5%
2.0%
2.5%
0 4 8 12 16 20 24 28 32 36 40 44 48 52 56 60 64 68 72 76 80 84
Age
2008 2021 2024
Average age
2008: 32.3 years
2021: 36.1 years
2024: 37.6 years
Chronic ratio (2008 – 2024)
0%
20%
40%
60%
80%
100%
0 4 8 12 16 20 24 28 32 36 40 44 48 52 56 60 64 68 72 76 80 84
Age
2008 2021 2024 (after CIB clean-up)
Chronic ratio
2008: 15.7%
2021: 30.8%
2024: 31.8%
ACTIVE Smart
(Launched 2025) PERSONAL HEALTH
PATHWAYS
(Launched 2025)
>61% Market share for 20-to-39-year-olds held
by Smart plans
R1 350 Lowest price point in the market

-- 33 of 81 --

34
Impact of doing Next Best Action | Net savings
to health funder
0%
20%
40%
60%
80%
100%
0% 25% 50% 75%
25% of members
complete NBA →
53% of potential
saving
Percentage saving
Diabetes	
Hypertension
0%
20%
40%
60%
80%
100%
0% 25% 51% 76%
Percentage saving
Percentage completing NBA
25% of members
complete NBA →
58% of potential
saving
Engaging members in a personalised program that incentivises
healthier habits and behaviour change
Percentage completing NBA
2.08m eligible lives
63% of activated lives are in the
chronic, disease prevention
or emerging risk cohort
348k Next Best Actions
completed since Jan 2025
PHP activation and engagement statistics as at 27 February 2025
R7.9m rewards earned

-- 34 of 81 --

35
The private healthcare sector is a strong asset – delivers
excellent value for members
Members have access to world-class care
Higher income countries South Africa
Cost of cover (PPP adjusted) 4
– 42%
3,347
14,709
8,346 11,073
34,504
Germany New
Zealand
South
Africa
UK USA
3,980
7,595
3,553 3,950
13,560
Germany New
Zealand
South
Africa
UK USA
South African prices compare favourably by international comparison3
Coronary angioplasty
(USD)
Appendectomy
(USD)
The private sector has significant scale
Open Medical
Schemes1
4.8m lives
Closed Medical
Schemes1
4.3m lives
838private facilities
42k
hospital beds
7.3k
GPs
47k
nurses
7k
specialists
3.5k
dentists
2.5k
optometrists
3.6k
psychologists
Community rated,
open to selection
1 2023 CMS Industry Report; 2 2023 General Household Survey: National Income Dynamics Study; 3 International healthcare cost comparison report 2024; 4 WHO expenditure database 2022
41.6% of SA households used the private
healthcare sector as as their last accessed care2

-- 35 of 81 --

36
Bigger issues surrounding medical inflation
High utilisation driving medical inflation
0%
2%
4%
6%
8%
10%
12%
14%
Overall
medical
inflation
Tariffs Supply
side
utilisation
Risk mngt,
Vitality
effect &
efficiencies
Demand
side
utilisation
1
2
3
3 key drivers of inflation can be broken down further:
Oncology drugs
(Keytruda,
Darzalex,...)
Next-generation
Sequencing
BioFire (multiplex
panels)
Robotic-assisted
surgeries
Biologics
Multiple sclerosis
treatments
Micra pacemaker
New technology and
treatments increase costs, but
members recognise the value
2
TECHNOLOGY
• Open enrolment
• Community rating
• Increased ageing
• Increased chronicity
3
DEMOGRAPHIC
ASPECTS
Increases access but leads
to adverse selection
1
TARIFFS
Tariff growth relative to CPI growth
(indexed to 2014) 
2014-2023 CAGR
+7.4%
Other
+11.6%
High-cost drugs
vs
90
100
110
120
130
140
150
160
170
2014
2015
2016
2017
2018
2019
2020	
2021
2022	
2023	
2024
Tariff increase CPI

-- 36 of 81 --

37
Bigger issues surrounding medical inflation
Longitudinal impact of medical inflation
100
120
140
160
180
200
220
240
260
280
2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
CPI Tariffs Tariffs+Supply Tariffs+Supply+Demand
Relative growth rates over last 10 years (indexed to 2014)
46% of medical inflation increase is
due to demand-side utilisation
(adverse selection)
Management of
contribution inflation
requires an overall
management
approach:
• Negotiation and price
regulation (tariffs)
• Networks and
directionality, value-
based care
integration (supply-
side)
• Hyper-personalisation
and personal health
pathways, growing
the effect of Vitality
(demand-side)
37% of medical inflation increase is
due to tariffs
Tariffs keep in line with CPI
17% of medical inflation increase is due
to supply-side utilisation (technology)
Accelerating and gap widening
COVID-19
CPI+6%
CPI+2%
CPI

-- 37 of 81 --

38
Discovery’s position: NHI is not
workable without private sector
collaboration

-- 38 of 81 --

39

-- 39 of 81 --

40
H1 2025	H1 2025	H1
2021
H1
2022
H1
2023
H1
2024
H1
2025
Individual Group
Discovery Life
Normalised profit New business
Maintained leading
market share
Strong capital and
liquidity
+15%
to R2 612m
Individual life:
+12%
SCR
coverage
Total
liquidity
183%
2 859m
1X ILT	125%
SCR Target
-4%
to R1 463m
Individual life:
0%
H1
2021
H1
2022
H1
2023
H1
2024
H1
2025
Individual Group
IFRS 17
2023 2024
12 months to Dec 2024
Competitor market
share relative to
Discovery Life
59%
47%
20%
NMG market report Q4 2024

-- 40 of 81 --

41
Discovery Life Ltd EV variances (Rm)
Robust performance with positive operating variances
Positive operating variances Excellent experience relative to assumptions
R261m
Policy alterations was a significant negative variance and slightly
improved from prior period. Action plan in progress
Mortality and morbidity
Persistency
Premium and fee
income
Policy alterations
Other
Total non-economic
Economic
Total
R468m
None Blue Bronze Silver Gold Diamond
Mortality experience by Vitality status relative to expected
H1FY25 experience	Jul 2019 – Dec 2024 Long-term
expected

-- 41 of 81 --

42
Robust EV growth and stable VNB margin
Growth in Embedded Value	Steady VNB margin
Jun-24
Economic
Business mix…
Other
Dec-24
3.8%
Individual life:
5.0%
(20.0% IRR)
3.6%
Jun
-24
Economic
Business mix	
and expenses
Other
Dec
-24
VNB margin (%)
Significant drop in Group Life new business volumes over a short
period. Individual Life margin benefits from lower interest rates
Individual life:
5.4%
(19.7% IRR)
20.6% Annualised RoEV*
*Annualised before the dividend payment.
June 2024
New Business
Expected Unwind
excl NB
Experience	
Variances
Basis changes	
Below the line
items
December 2024
25948 239
2265 469
1487 30020
R45 948m
R50 028m
14.1% excluding economic updates
-380

-- 42 of 81 --

43
Strong cashflow generation
Life and Invest cash significantly ahead of target
Cashflow before financing initiatives and
dividends to Group (Rm)
Cashflow over time
545
1,093
1,523
Dec-21	
Dec-22	
Dec-23	
Dec-24
Dec 2021
Covid
impact
Dec 2022 Dec 2023 Dec 2024
Premiums & fees &
investment income
Cash outflows Cash outflows	Cashflow before
financing/funding
to group
R1 523m
R11 539m
-R6 112m
Claims
-R2 128m
Operational
costs
-R1 776m
New business
cash
conversion
ratio
>60%
981 429
Financing
repayment
Dividend to Group
(Rm)
R981m R429m
Exceptionally high this period given favourable claims in Indiv Life, Group Life and strong fee
performance in Invest, plus lower new business strain
-848

-- 43 of 81 --

44
Value generation of business under IFRS 17
Store of value absorbs variances and plays out as earnings during the period
IFRS 17 Life and Invest GMM business stored valued
absorbs variances and basis changes
Components of Life segment earnings
(incl PAA business such as Group Life)
Economic
margin
New
business
Release
to
earnings
Non
-economic
margin
June
2024
December
2024
CSM
20,237
RA
7,243
OCI
-3,980
23,499 27,432
1,043
-1,102
CSM
20,324
RA
8,042
ZARm
Life = 886
Invest = 216
=
Life
segment
earnings
2,612
CSM & RA
release
886
IFIE
1,349
Other2
378
= c17%
Growth from
June 2024
1,894 -949
517
2,528
Net impact
of
-R432m
Net impact
of
+R4.4bn1
OCI
-935
1
2
Favourable claims experience
offsets reduction in current
period IFIE due to June 24
systematic rate movements
3
Total margin up c17% from
R23.5bn in June 24 to R27.4bn
in December 24 (+c3% excl.
OCI)
Significant gains reflected in
OCI driven by lower interest
rates in December 24 vs June 24
1 Includes changes to assumptions related to financial risk 2 “Other” includes largely PAA business earnings and variances such as the favourable claims experience variance in the period and non-directly attributable expenses.
Insurance
finance
income/
expense1
Non-
financial risk
variances
and basis
changes

-- 44 of 81 --

45

-- 45 of 81 --

46
Discovery Invest
Normalised profit New business Assets under administration
+46% +7% +15%
to R904m to R1 735m to R167bn
Jan-18	
Jul-18	
Jan-19	
Jul-19
Jan-20	
Jul-20	
Jan-21	
Jul-21
Jan-22	
Jul-22	
Jan-23	
Jul-23	
Jan-24	
Jul-24
H1
2021
H1
2022
H1
2023
H1
2024
H1
2025
H1
2021
H1
2022
H1
2023
H1
2024
H1
2025
Once-off items
+19%
Excl
once-offs
IFRS 17

-- 46 of 81 --

47

-- 47 of 81 --

48
H1
2021
H1
2022
H1
2023
H1
2024
H1
2025
H1
2021
H1
2022
H1
2023
H1
2024
H1
2025
Discovery Insure
Solvency	Normalised profit Insurance revenue
>100% +10%
to R372m to R3 078m
IFRS 17
H1
2021
H1
2022
H1
2023
H1
2024
H1
2025
198%
Personal lines
-1%
to R659m
H1
2021
H1
2022
H1
2023
H1
2024
H1
2025
Gross new business

-- 48 of 81 --

49
New business based on
insurance risk exposure
Vitality continues to drive improvement in quality
Disciplined
approach to
underwriting
Targeted premium
increases
Lower severity by
status
Retaining the
right clients
Relative average
anniversary increase by
status
Relative lapse rate by
status
0%
20%
40%
60%
80%
100%
Blue
Bronze
Silver
Gold
Diamond
 0%
20%
40%
60%
80%
100%
Blue
Bronze
Silver
Gold
Diamond
Relative accident severity
by Vitality status
0%
20%
40%
60%
80%
100%
Blue
Bronze
Silver
Gold
Diamond
0%
40%
80%
120%
Jul 19	
Jan 20	
Jul 20	
Jan 21	
Jul 21
Jan 22	
Jul 22	
Jan 23	
Jul 23	
Jan 24	
Jul 24
Above-average Average	Average
risk
Superior risk
Lower loss ratio by
status
Relative loss ratio by
Vitality status
0%
20%
40%
60%
80%
100%
Blue
Bronze
Silver
Gold
Diamond

-- 49 of 81 --

50
Strong margin recovery from management actions taken
Claims
initiatives
0.3%
Behaviour
change
1.3%
Other
external
factors
FY24 H1
Margin
2.4%
Unexpected
weather
improvement
FY25 H1
margin
2.6%
Expected
weather
improvement
0.6%
Upfront
selection
1.2%
Underwriting
actions
1.3%
Pricing
actions
0.5%
Selective
lapsation
uplift
1.8%
0.1%
FY25 H1
margin
before
unexpected
weather
improvement
9.7%
12.1%
Profit margin based on insurance revenue

-- 50 of 81 --

51
0%
2%
4%
6%
2012	
2013	
2014	
2015	
2016	
2017	
2018	
2019	
2020	
2021	
2022	
2023	
2024
0k - 200k
200k - 300k
300k - 500k
500k+
Material and consistent decrease in theft over time
Decrease in theft
rate over time
Consistent trend by
sum insured Consistent by geography
0%
1%
2%
3%
4%
2013	
2014	
2015	
2016	
2017	
2018	
2019	
2020	
2021	
2022	
2023	
2024
 0%
1%
2%
3%
4%
5%
2012	
2013	
2014	
2015	
2016	
2017	
2018	
2019	
2020	
2021	
2022	
2023	
2024
Gauteng
Western
Cape
KZN
Other
Theft rate Theft rate by sum insured Theft rate by province
0%
2%
4%
6%
8%
2012	
2013	
2014	
2015	
2016	
2017	
2018	
2019	
2020	
2021	
2022	
2022	
2024
 0%
2%
4%
6%
8%
2012	
2013	
2014	
2015	
2016	
2017	
2018	
2019	
2020	
2021	
2022	
2022	
2024
0k - 500k
500k - 750k
750k - 1m
1m +
Theft rate Theft rate by sum insured Theft rate by province
Motor
theft
House
and
contents
theft
0%
4%
8%
12%
2012	
2013	
2014	
2015	
2016	
2017	
2018	
2019	
2020	
2021	
2022	
2022	
2024
Gauteng
Western
Cape
Kwazulu-
Natal
Other
KZN

-- 51 of 81 --

52
Vitality
Successfully actioned significant price increases to
mitigate increased PMI utilisation on the back of NHS
pressure, with a strong retention of in-force business
Strong increase in quality new business in a
commoditised and stagnant UK market
Strong margin expansion and integrated API growth,
demonstrating the global relevance of the Shared-
value Insurance model
Excellent progress in growing quality health insurance
driven by continued operating delivery and strong
gains from Chinese bond and equity market
movements
Vitality USA acquired WellSpark, expanding beyond
employee wellness into broader integrated digital
health and care market. Amplify Health progressed in
deploying healthtech solutions across Asia

-- 52 of 81 --

53
A single global composite:
Single Vitality chassis to establish a unified approach to
personalisation across markets, enhancing customer engagement and
loyalty
Inter-operable technology platforms and consistent global
enablement to achieve operational efficiencies, improved systems
integration, scalability and reduced costs
Single, more prominent brand to achieve greater brand recognition
and market differentiation
Five centres of excellence to share best practice and ensure an
appropriate level of alignment across the business
Unified partner network to maximise benefits to our members while
driving efficiencies globally

-- 53 of 81 --

54
Incentivising behaviour change through hyper-personalised
pathways
Physical activity has a significant
impact on mortality
Causal Elastic Habitual
Behavioural dynamics are universal, holding
across ages and health status
Habits form quickly and easily, yet their
true strength lies in their durability
-29%
-52% -59%
0 (base) Low Medium High
-36% -38% -58%
0 (base) Low Medium High
Relative mortality for the 45-65
age group
Relative mortality for the 65+ age
group
0%
5%
10%
15%
20%
25%
30%
35%
40%
45%
6 9 12 15 18 21 24 27
Percentage
Number of weeks taken to form a habit
7 – 15
weeks
Peak around
10 weeks
Young moderately
healthy 30-year-old 10.2
56.7
43.5 53.7
Healthspan Sick years
10	46.7
Middle age unhealthy
50-year-old 1
0.
2
16.6 24.9
Healthspan Sick years
25.1
Advanced age
unhealthy 70-year-old 4
14.6
6.1 10.1
Healthspan Sick years
11.6
+7%
increase in
healthspan
+51%
increase in
healthspan
+90%
increase in
healthspan
8.3
33.5	8.4
3

-- 54 of 81 --

55
Vitality AI is the breakthrough solution
for traditional model inefficiencies
Dynamic pricing
Incentivised
engagement
AI recommender
Dynamic risk
assessment
Data
Key value drivers
1. New business
2. Selection
3. Behaviour change
4. Selective lapsation
5. Upsell / cross-sell
Enhanced
VoNB / IRR

-- 55 of 81 --

56
UK

-- 56 of 81 --

57
H1
2021
H1
2022
H1
2023
H1
2024
H1
2025
Vitality UK
Normalised profit Premium income New business Lives covered
+12% +14% +10% +7%
to £40.0m to £610m to £104.9m to 1.9m
GBP millions	
GBP millions
+12%
to R14.1bn
+9%
to R2.4bn
+11%
to R926m
H1
2021
H1
2022
H1
2023
H1
2024
H1
2025
H1
2021
H1
2022
H1
2023
H1
2024
H1
2025
H1
2021
H1
2022
H1
2023
H1
2024
H1
2025
GBP millions
IFRS 17

-- 57 of 81 --

58
H1
2021
H1
2022
H1
2023
H1
2024
H1
2025
H1
2021
H1
2022
H1
2023
H1
2024
H1
2025
VitalityHealth
Normalised profit Premium income1 New business Lives covered
+15% +16% +3% +6%
to £25.9m to £394m to £57.3m to 1.0m
IFRS 17
GBP millions	
GBP millions	
GBP millions
+15%
to R9.1bn
+2%
to R1.3bn
+14%
to R599m
H1
2021
H1
2022
H1
2023
H1
2024
H1
2025
H1
2021
H1
2022
H1
2023
H1
2024
H1
2025
1 Insurance revenue

-- 58 of 81 --

59
40%
60%
80%
100%
120%
Jan
Feb
Mar
Apr
May	
Jun
Jul
Aug	
Sep
Oct
Nov	
Dec
2022
2023
2024
Retention resilient despite pricing actions, expect recovery of
margins
Increase in claims
costs
Shift towards
primary care
Selective retention
of healthier lives
Expect a recovery
of margins
Claim categories PLPM
(indexed)
Lapse rates vs premium
increase by Vitality status
Claims PLPM over time Normalised profit
(GBPm)
H1
2023
H2
2023
H1
2024
H2
2024
H1
2025
40%
60%
80%
100%
120%
Lapse rate
Average increase
+13%
+9%
FY23 FY24
Pricing actions
implemented
Premiums vs claims
PLPM (rebased to Jan 24)
FY2025
85%
90%
95%
100%
105%
110%
115%
Jan
24
Mar
24
May
24
Jul
24
Sep
24
Nov
24
Rolling 3m average
Premium PLPM
Rolling 3m average
Claims PLPM
-
1
2
3
4
5
6
VGP
consultation
+477%
Talking
Therapies
+107%
Tumours
+21%
Cardiac
+15%
Oncology
+19%

-- 59 of 81 --

60
H1
2021
H1
2022
H1
2023
H1
2024
H1
2025
H1
2021
H1
2022
H1
2023
H1
2024
H1
2025
H1
2021
H1
2022
H1
2023
H1
2024
H1
2025
H1
2021
H1
2022
H1
2023
H1
2024
H1
2025
VitalityLife
Normalised profit* New business	Premium income Lives covered
+8% +10% +19% +9%
to £14.1m to £217m to £47.6m to 852k lives
IFRS 17
GBP millions	
GBP millions	
GBP millions
+9%
to R5bn
+18%
to R1.1bn
+8%
to R327m
*H1 2024 has been restated for IFRS17 accounting methodology changes applied in 30 June 2024 reporting

-- 60 of 81 --

61
Price optimisation in a commoditised, portal-driven market
Sophisticated price optimisation and elasticity provides opportunity for Optimiser to compete on portals
Optimiser allows us to compete on portals
where price plays an important role
61%	
of cases, Optimiser is cheapest
1%	
away from the cheapest, on average
Up to
30%
lower than standard plan rates
Dynamic rating enables us to accurately
account for controllable risk throughout the
policy duration
Regular and ongoing engagement through
interactions that drive positive behaviour
change
Vitality
premium
(Optimiser)
Policy duration
Premium
Competitor
premium
Corridor of competitiveness
Illustrative pricing	Portal-driven market

-- 61 of 81 --

62
Exceptional new business growth in a stagnant market
Significant change in
value
Growing net new
business value
New business net value
(£m)
VL continues to generate strong
levels of net new business value. If
maintained, VL’s CSM and RA will
grow for the year
39% net growth, despite
a flat market
VL new business growth
+19% vs market excl VL -1%1
New business (£m)
29.1
40.5
10.8
7.1	39.9
47.6
H1 FY2024 H1 FY2025
Automatic Contribution Increases (ACIs)
Net new business (i.e. excl. ACIs)
+39%
+19%
Indicative IRR hurdle2
Establishing solid
market share
Key competitors:
VitalityLife market share1
-1
0
1
2
3
4
5
1. GenRe Protection Pulse; 2. IRR hurdle line is indicative of the average monthly level of net new business value required to achieve VL's internal IRR hurdle rate, but in practice this will vary dependent on the relative level of fixed expenses, new business and profitability;
3. CSM & RA” on NB excludes the impact of new reinsurance contracts attaching to the in-force book in the period. The total CSM and RA on all contracts incepted in the period was £13.3m (new business net value excluding financing)
7.5% 7.4%
10.1% 10.5%
12.4%
H1
FY21
H1
FY22
H1
FY23
H1
FY24
H1
FY25
£24.3m from -£0.2m in H1 FY24
New business net value
(£m)3 (CSM and RA, less
onerous new business)
VNB (£m)
£2.6m from -£5.7m in H1 FY24

-- 62 of 81 --

63
Value generation of business under IFRS 17
1 New business net value excludes the impact of new reinsurance contracts attaching to the in-force book in the period. The total CSM and RA on new contracts incepted in the period was £16m. The difference is included in ‘Non-financial risk, variance,
basis changes and other’ ; 2 Includes changes to assumptions related to financial risk
IFRS 17 stored value absorbs variances and basis changes Components of VitalityLife earnings
Economic
margin
New
business1
Insurance
finance
income/
expense2
Non-
financial risk
variances,
basis
changes
and other
Release
to
earnings
Non
-economic
margin
June
2024
December
2024
CSM
329
RA
77
OCI
112
518 535
2
26 -20
-8
7
9
OCI
128
CSM
327
RA
80
19.6
OCI
128
RA
80
Net impact
of -£1m
VL
earnings
14.1
CSM &
RA
release
19.6
IFIE
6.3
Other
-11.8
=
1 Total margins increased by c3% from
£518m at June 24 to £535m at
December 24
2
Non-economic margins increased
slightly from June 24 to December 24.
This is an important feature for future
earnings
Strong levels of margins generated
on new business more than offset
release of CSM & RA to earnings
3
Non attributable costs, in period
cashflow variances and impact of
onerous business (after establishing a
risk margin) marginally offset CSM &
RA release and positive IFIE in earnings
4
Store of value absorbs variances and plays out as earnings during the period GBPm
Net impact
of +£11m
= c3%
Growth from
June 2024

-- 63 of 81 --

64
Strategic vision for Vitality UK
Focused
ambition
Enabled by
powerful
shared value
differentiators
Supported by
an aspirational
brand
Transforming the UK health
and life insurance markets
through shared value
powered by Vitality AI
Underpinned by clear objectives
Highest brand
recognition in the
market
Top 3 UK
health and life
insurer
Renowned for
market-leading
customer service
Changing behaviour
through hyper-
personalisation
Advanced price optimisation drives growth in
profitable segments
Shared-value product features manage risk over time
Optimiser Employer
cashback
Status-linked
excess
ABC pricing
£150
£100
£100
£0
Bold messaging that emphasises
insurance as a tool for living a
richer, longer life
Vitality helps members live up to
5 years longer
Externally
validated
Partnered with leading brands Brought to life across the UK
Ambassadors Sponsorship portfolio
Football Cricket
Netball Running Media

-- 64 of 81 --

65
Network

-- 65 of 81 --

66
H1
2021
H1
2022
H1
2023
H1
2024
H1
2025
H1
2021
H1
2022
H1
2023
H1
2024
H1
2025
H1
2021
H1
2022
H1
2023
H1
2024
H1
2025
Vitality Network
Integrated API by
insurance partners Revenue
Insurance partners
membership	Normalised profit
+13%
to $909m
+8%
to R16.3bn
+8%
to $54.1m
+3%
to R970m
+20%
to $18.9m
+15%
to R339m
+26%
to 6.2m
H1
2021
H1
2022
H1
2023
H1
2024
H1
2025
USD millions	
USD millions	
USD millions

-- 66 of 81 --

67
Vitality Network’s key strategic focus areas
Revenue growth through
deepening of existing partnerships
and pursuit of new opportunities
Unlock geared profits through
operational efficiencies
generated from scaling
1
2
3
Strong performance from
John Hancock with 29%
increase in performance
fees
+4% Increase in profit
margin from
H1FY2024-H1FY2025
Profit margin
24%
20%
26%
31%
35%
H1 2021 H1 2022 H1 2023 H1 2024 H1 2025
35% Profit margin
for H1FY2025
Substantial growth from
SLI with 2 million
Vitality policies sold
Evolving Vitality products
through hyper-personalisation
and Vitality AI
Rebuild of mobile app to enable greater hyper-
personalisation and member engagement
Leveraging Vitality AI to drive
engagement
New mobile
experience
successfully launched
across 3 markets –
Pakistan, Netherlands
and Ecuador

-- 67 of 81 --

68
Positive impact of shared value observed across markets
Claims correlations Lapse correlations
Blue Bronze Silver Gold
63%
lower
47%
lower
Blue Bronze Silver Gold Diamond Blue Bronze Silver Gold Diamond
53%
lower
57%
lower
27%
market share
Blue Bronze Silver Gold
70%
lower
~12%
market share Bronze Silver Gold Platinum
36%
lower
Bronze Silver Gold Platinum
Member engagement
2019 2024
2019 2024
64%
Member
engagement
% of members
earned a point
6%
increase in
proportion of
off-Blue
members
4th largest
life insurance
market
3rd largest
life insurance
market
2019 2024
Consistent
member
engagement

-- 68 of 81 --

69

-- 69 of 81 --

70
H1
2021
H1
2022
H1
2023
H1
2024
H1
2025
Investment income and gains
Profit before investment income
and gains
Ping An Health Insurance
PAHI’s operating
results pre-tax
Discovery’s operating
result after tax
PAHI licence
new business1
PAHI licence
earned premium1
+62% +27% +10%	+16%
to RMB906m
(RMB226m DSY’s
share)
to RMB170m to RMB1.7bn	to RMB8.3bn
Lives
+11%
to 29.1m PAHI licence
lives
+57% +23% +6%	+13%
to R2.3bn
(R565m DSY’s
share)
to R424m to R4.4bn	to R20.7bn
1 100% of PAHI
RMB millions	
RMB millions	
RMB millions	
RMB millions
19-Jun	
19-Dec	
20-Jun	
20-Dec	
21-Jun	
21-Dec	
22-Jun	
22-Dec	
23-Jun	
23-Dec	
24-Jun	
24-Dec
H1
2021
H1
2022
H1
2023
H1
2024
H1
2025
H1
2021
H1
2022
H1
2023
H1
2024
H1
2025
-14%
before
investment
income
H1
2021
H1
2022
H1
2023
H1
2024
H1
2025

-- 70 of 81 --

71
Superior operational performance and growth
65%
70%
75%
80%
85%
90%
2021 2022 2023 2024
50%
60%
70%
80%
90%
100%
2020 2021 2022 2023 2024
Strong persistency
Improving operating
performance
Significant balance sheet
growth
Combined ratio (%)	Reapplication rates (%) Net asset value (RMB millions)
0
2,000
4,000
6,000
8,000
10,000
12,000
2020 2021 2022 2023 2024

-- 71 of 81 --

72
Increasing demand for private healthcare drives growth
in Commercial Health Insurance
0
200
400
600
800
1 000
1 200
1 400
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
2033
2034
2035
2036
2037
2038
2039
2040
2041
2042
2043
2044
2045
2046
2047
2048
2049
2050
65 and above
50-64
40-49
30-39
20-29
<20
China's population by age band1 (m)
China's aging population calls for a high-quality, multi-levelled,
Commercial Health Insurance system
Rising volumes of health risks put pressure on the Social Health Insurance
+3.6%
Increase in Commercial Health Insurance
spending as a share of China's total healthcare
expenditure3
Evolving factors drive further
private healthcare demand
From 2015 to 2021, China has seen…
Macroeconomic factors
Micro-sectoral factors
Renewed fiscal and monetary stimuli to counter
past macroeconomic headwinds, unleashing
the health sector's underlying growth4
Expected expansion of tax incentives for
Commercial Health Insurance5
Rising demand for original medicine drives
health insurance demand6
Fiscal constraints shift healthcare spending
pressure towards households7
+20% Rise in diabetes & kidney
diseases disability adjusted life
years (DALYs)2
+13% Rise in neoplasms
DALYs2
Sources: 1. China Briefing (2021) | 2. Institute for Health Metrics and Evaluation (n.d.) | 3. China Macro Group (2024) | 4. Reuters (2024) | 5. National Financial Regulatory Authority (2024) | 6. BBC (2025) | 7. China Pharmaceutical Innovation and Research Development Association (2024)
+12% Rise in cardiovascular disease
DALYs2
-1.8%
Decrease in Social Health Insurance spending as
a share of China's total healthcare expenditure3

-- 72 of 81 --

73
PAHI continues to grow in a competitive market
Scale
Q1 – Q3 2024
1 2 RMB15.6bn
PAHI leads health & wellness service-driven specialised health insurance.
Through its health ecosystem of “insurance + health services + health
management”, PAHI ensures that policyholders are not only insured against
disease but also actively manage and improve their health. It leverages the
shared-value model of insurance to retain customers and control risk
2 1 RMB44.0bn1
An early entrant in the specialised health insurance, PICC Health is a state-
owned entity that leverages government resources and holds competitive
position in “policy-backed health insurance” market (e.g., major illness
insurance). Its business is integrated with the SHI, reaching a large
population in third- and fourth- tier cities and rural areas
3 3 RMB6.0bn CPIC Health products lead towards standardisation. Its strengths lie in its
cooperative network with public hospitals and group supplementary medical
insurance for corporate employees
4 4 RMB4.3bn
Fosun Health has the advantageous access to Fosun Pharma’s
pharmaceutical and medical products and innovation. Fosun Health focuses
on the integration between medicine and insurance and is known for
covering innovative drugs and cutting-edge treatment
5 5 RMB1.2bn
Ruihua Health Assurance’ products are tailored to four clearly defined market
segments: special care (for chronic conditions), urgent care (for high end
customers), long-term care (for elderly), and affordable solutions. Ruihua
focuses on digitalisation, technology integration, and customer service,
making it popular amongst the digitally-savvy customers
Total health insurance
premiums written by all
financial institutions in
China
RMB822.5bn (100%)
Health insurance
premiums written by
specialised health insurers
RMB71.1bn (9%)
Profit
margin
rank
Market
share
rank
1 PICC health insurance premiums included RMB11bn of major illness insurance, which is beyond the business scope of PAHI

-- 73 of 81 --

74
Strong performance relative to market
Note: 1. PAHI's market share of accessible sectors of the market
High growth relative to market Growing market share
Superior operational
performance
Revenue growth (rebased) PAHI market share (%)1 Net profit margin
0
1
2
3
4
5
2018 2019 2020 2021 2022 2023 2024
Market PAHI
2.3x
higher
9.9%
10.4%
10.6%
10.8%
11.7%
2020 2021 2022 2023 2024
-4%
-2%
0%
2%
4%
6%
8%
10%
2019 2020 2021 2022 2023

-- 74 of 81 --

75
VHI

-- 75 of 81 --

76
Vitality Health International (Other)
Note: Quantium Health, which is part of VHI, has not been included in this update
1
2
3
1
2
Acquisition of WellSpark, from EmblemHealth, a
prominent New York health plan administrator
Continued progress in sales to US health plans, a
key strategic segment, and expansion into
significant Medicare Advantage market
Strong progress in product and technology
implementation, particularly Vitality AI, and
execution of cost efficiencies
Successful deployment of nine health tech
solutions across six Asian markets1
Integrated product stack now included in Amplify
Health’s overall proposition for deployment to AIA
markets and external clients
Benefit	
navigation	
Care	
navigation	
Enrollment Onboarding Member	
service	
Wellness Coaching Care	
management	
Virtual	
medical	
care
Claims	Condition	
management
Coaching	
platform	
further	
enhances	
offering	
Vitality
USA
capability
Vitality 3.0 Care Connector
platform
Vitality AI
Business
Solutions
Advisory
Managed
Services
Products (SaaS)
Digital Health Engagement
Payment Integrity
Claims Administration
Business Intelligence
Clinical Informatics
Data Platform (DaaS)	
Data Commercialisation Enabler
Healthtech Launchpad
(PaaS)	
Innovation Accelerator
1. Excludes deployments by Amplify Health (Hong Kong) Limited

-- 76 of 81 --

77
In summary

-- 77 of 81 --

78
Key insights from H1 FY2025 performance
1
2
4
Growth
Consistency
Profit
growth
27%
% spend on
New
5%
Cash
conversion
ratio
75%
RoE
15%
FLR
18%
Interim
dividend
growth
34%
Health Life Invest Insure Bank VH VL VN
+57%	+8%
Normalised profit growth
+15% +46% >100% +14% +8% +15%
PAHI
+23%
3
Shared value
Blue Bronze Silver Gold Diamond
Significant
status
correlations
Using
shared-value
model in
response to
industry
trends
Resilience
1. Liability matching
2. Interest rates hedged
3. Currency matching
4. Appropriate liquidity buffers
5. Mitigate lapse risk
6. Monitor new initiatives
Set of defined
risk principles
Resilient to
stresses
80%
90%
100%
110%
FY2025 FY2026 FY2027 FY2028 FY2029

-- 78 of 81 --

79
Strong prospects for growth in the Group’s new lifecycle
*65% cash conversion ratio from target profit growth (assuming constant debt and 5.0x dividend cover) generates strong net cash flow and cash to centre (assuming 50% retained in business)
Forward looking information on this slide is for illustration and has not been reviewed or reported on by the auditors and reflects the average expected over the time frame
Vitality AI next dimension of
shared-value model
Strong growth from the
composites
Strong growth gives resilience
and optionality
12.5% to
17.5%
20% to
30%
average earnings
growth p.a.
(FY25-FY29)
average earnings
growth p.a.
(FY25-FY29)
15-20%
CAGR
Illustrative Group leverage and accumulated
excess cash at the centre*
Up to cR10bn excess cash generated
over the next five years
Excess cash available to
• Repay debt and/or
• Invest in new initiatives and/or
• Increase dividend payout
16%
15%
13%
12%
-
2,000
4,000
6,000
8,000
10,000
12,000
FY26 FY27 FY28 FY29

-- 79 of 81 --

80
Presentation disclaimer
This presentation contains information extracted from the Discovery Group’s unaudited
condensed consolidated interim financial statements for the six months ended 31 December
2024. This results presentation and the unaudited condensed consolidated financial
statements have not been reviewed or reported on by Discovery’s independent joint
auditors.
This presentation may contain forward looking statements with respect to certain of
Discovery’s plans and its current goals and expectations relating to its future performance
and results. All forward looking statements involve risk and uncertainty because they relate
to future events and circumstances which are beyond Discovery’s control. Accordingly,
Discovery’s actual future financial performance and results may differ. Any reference to
future financial performance has not been reviewed or reported on by the Group’s auditors.

-- 80 of 81 --

Unaudited Interim Results
and cash dividend declaration for the six
months ended 31 December 2024

-- 81 of 81 --